Lung disease and brain development

Biology of the Neonate

Volumn 89, Issue 4, 2006, Pages 284-297

  Hüppi, Petra ^a,c,d   Sizonenko, Stephane ^a   Amato, Maurizio ^b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d Hopital des Enfants Hopitaux universitaires de Geneve   (Switzerland)

Author keywords

Developmental plasticity; Glucocorticoids; Magnetic resonance imaging; Prematurity

Indexed keywords

BETAMETHASONE; CONTRAST MEDIUM; CORTICOSTEROID; DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; INOTROPIC AGENT; NEUROPROTECTIVE AGENT;

ADAPTATION; ARTIFICIAL VENTILATION; BRAIN DEVELOPMENT; BRAIN DISEASE; BRAIN MALFORMATION; CHRONIC LUNG DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; DEVELOPMENTAL DISORDER; DIAGNOSTIC ACCURACY; DRUG EFFECT; DRUG POTENCY; ENVIRONMENTAL FACTOR; HUMAN; INFLAMMATION; LOW DRUG DOSE; LUNG DEVELOPMENT; LUNG DISEASE; LUNG DYSPLASIA; LUNG HYPOPLASIA; NERVE CELL PLASTICITY; NEUROIMAGING; NEUROLOGIC DISEASE; NEWBORN INTENSIVE CARE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PERINATAL MORTALITY; PREMATURITY; PRIORITY JOURNAL; SURVIVAL RATE; TISSUE DIFFERENTIATION;

ANIMALS; BRAIN; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; LUNG DISEASES; NEURONAL PLASTICITY; OXIDATIVE STRESS;

EID: 33745064475     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092865     Document Type: Conference Paper

References (103)

1. Wood NS, Costeloe K, Gibson AT, Hennessy EM, Marlow N, Wilkinson AR: The EPICure study: associations and antecedents of neurological and developmental disability at 30 months of age following extremely preterm birth. Arch Dis Child Fetal Neonatal Ed 2005;90:F134-F140.
2. Hack M, Taylor HG, Drotar D, Schluchter M, Cartar L, Andreias L, Wilson-Costello D, Klein N: Chronic conditions, functional limitations, and special health care needs of school-aged children born with extremely low-birth-weight in the 1990s. JAMA 2005;294:318-325.
3. Marlow N, Wolke D, Bracewell MA, Samara M: Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J Med 2005;352:9-19.
4. West-Eberhard MJ: Evolution in the light of developmental and cell biology, and vice versa. Proc Natl Acad Sci USA 1998;95:8417-8419.
5. Bateson P, Barker D, Clutton-Brock T, Deb D, D'Udine B, Foley RA, Gluckman P, Godfrey K, Kirkwood T, Lahr MM, McNamara J, Metcalfe NB, Monaghan P, Spencer HG, Sultan SE: Developmental plasticity and human health. Nature 2004;430:419-421.
6. Gluckman PD, Hanson MA: Living with the past: evolution, development, and patterns of disease. Science 2004;305:1733-1736.
7. Sperling MA: Prematurity: a window of opportunity? N Engl J Med 2004;351:2229-2231.
8. Johnston MV: Clinical disorders of brain plasticity. Brain Dev 2004;26:73-80.
9. Blaschke AJ, Staley K, Chun J: Widespread programmed cell death in proliferative and postmitotic regions of the fetal cerebral cortex. Development 1996;122:1165-1174.
10. Bredesen D: Neural apoptosis. Ann Neurol 1995;38:839-851.
11. Vaudry D, Falluel-Morel A, Leuillet S, Vaudry H, Gonzalez BJ: Regulators of cerebellar granule cell development act through specific signaling pathways. Science 2003;300:1532-1534.
12. Casaccia-Bonnefil P: Cell death in the oligodendrocyte lineage: a molecular perspective of life/death decisions in development and disease. Glia 2000;29:124-135.
13. Dong WK, Greenough WT: Plasticity of non-neuronal brain tissue: roles in developmental disorders. Ment Retard Dev Disabil Res Rev 2004;10:85-90.
14. Changeux JP, Danchin A: Selective stabilisation of developing synapses as a mechanism for the specification of neuronal networks. Nature 1976;264:705-712.
15. Lagercrantz H, Ringstedt T: Organization of the neuronal circuits in the central nervous system during development. Acta Paediatr 2001;90:707-715.
16. Lilienbaum A, Israel A: From calcium to NF-kappa B signaling pathways in neurons. Mol Cell Biol 2003;23:2680-2698.
17. Wang Y, Chan SL, Miele L, Yao PJ, Mackes J, Ingram DK, Mattson MP, Furukawa K: Involvement of Notch signaling in hippocampal synaptic plasticity. Proc Natl Acad Sci USA 2004;101:9458-9462.
18. Gutierrez H, Hale VA, Dolcet X, Davies A: NF-kappaB signalling regulates the growth of neural processes in the developing PNS and CNS. Development 2005;132:1713-1726.
19. Mattson MP, Camandola S: NF-kappaB in neuronal plasticity and neurodegenerative disorders. J Clin Invest 2001;107:247-254.
20. Cheema ZF, Wade SB, Sata M, Walsh K, Sohrabji F, Miranda RC: Fas/Apo [apoptosis]-1 and associated proteins in the differentiating cerebral cortex: induction of caspase-dependent cell death and activation of NF-kappaB. J Neurosci 1999;19:1754-1770.
21. Casey BJ: Brain plasticity, learning, and developmental disabilities. Ment Retard Dev Disabil Res Rev 2003;9:133-134.
22. Diamond A, Briand L, Fossella J, Gehlbach L: Genetic and neurochemical modulation of prefrontal cognitive functions in children. Am J Psychiatry 2004;161:125-132.
23. Digicaylioglu M, Garden G, Timberlake S, Fletcher L, Lipton SA: Acute neuroprotective synergy of erythropoietin and insulin-like growth factor I. Proc Natl Acad Sci USA 2004;101:9855-9860.
24. Sweet DG, Halliday HL: Modeling and remodeling of the lung in neonatal chronic lung disease: implications for therapy. Treat Respir Med 2005;4:347-359.
25. Warburton D, Zhao J, Berberich MA, Bernfield M: Molecular embryology of the lung: then, now, and in the future. Am J Physiol 1999;276:L697-L704.
26. Ohmori M, Harii N, Endo T, Onaya T: Tumor necrosis factor-alpha regulation of thyroid transcription factor-1 and Pax-8 in rat thyroid FRTL-5 cells. Endocrinology 1999;140:4651-4658.
27. DiCosmo BF, Geba GP, Picarella D, Elias JA, Rankin JA, Stripp BR, Whitsett JA, Flavell RA: Airway epithelial cell expression of interleukin-6 in transgenic mice. Uncoupling of airway inflammation and bronchial hyperreactivity. J Clin Invest 1994;94:2028-2035.
28. Saugstad OD: Bronchopulmonary dysplasia-oxidative stress and antioxidants. Semin Neonatol 2003;8:39-49.
29. van der Vliet A, Cross CE: Oxidants, nitrosants, and the lung. Am J Med 2000;109:398-421.
30. Lin YJ, Markham NE, Balasubramaniam V, Tang JR, Maxey A, Kinsella JP, Abman SH: Inhaled nitric oxide enhances distal lung growth after exposure to hyperoxia in neonatal rats. Pediatr Res 2005;58:22-29.
31. Muraoka RS, Bushdid PB, Brantley DM, Yull FE, Kerr LD: Mesenchymal expression of nuclear factor-kappaB inhibits epithelial growth and branching in the embryonic chick lung. Dev Biol 2000;225:322-338.
32. Dammann O, Leviton A: Brain damage in preterm newborns: biological response modification as a strategy to reduce disabilities. J Pediatr 2000;136:433-438.
33. Hagberg H, Mallard C: Effect of inflammation on central nervous system development and vulnerability. Curr Opin Neurol 2005;18:117-123.
34. Baud O, Zupan V, Lacaze-Masmonteil T, Audibert F, Shojaei T, Thebaud B, Ville Y, Frydman R, Dehan M: The relationships between antenatal management, the cause of delivery and neonatal outcome in a large cohort of very preterm singleton infants. Br J Obstet Gynaecol 2000;107:877-884.
35. Romero R, Gomez R, Ghezzi F, Yoon BH, Mazor M, Edwin SS, Berry SM: A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol 1998;179:186-193.
36. Yoon BH, Romero R, Kim CJ, Koo JN, Choe G, Syn HC, Chi JG: High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia. Am J Obstet Gynecol 1997;177:406-411.
37. Viscardi RM, Muhumuza CK, Rodriguez A, Fairchild KD, Sun CC, Gross GW, Campbell AB, Wilson PD, Hester L, Hasday JD: Inflammatory markers in intrauterine and fetal blood and cerebrospinal fluid compartments are associated with adverse pulmonary and neurologic outcomes in preterm infants. Pediatr Res 2004;55:1009-1017.
38. Kahn MA, De Vellis J: Regulation of an oligodendrocyte progenitor cell line by the interleukin-6 family of cytokines. Glia 1994;12:87-98.
39. Marin-Padilla M: Developmental neuropathology and impact of perinatal brain damage. II. White matter lesions of the neocortex. J Neuropathol Exp Neurol 1997;56:219-235.
40. Kadhim H, Tabarki B, Verellen G, De Prez C, Rona AM, Sebire G: Inflammatory cytokines in the pathogenesis of periventricular leukomalacia. Neurology 2001;56:1278-1284.
41. Kadhim H, Tabarki B, De Prez C, Sebire G: Cytokine immunoreactivity in cortical and subcortical neurons in periventricular leukomalacia: are cytokines implicated in neuronal dysfunction in cerebral palsy? Acta Neuropathol (Berl) 2003;105:209-216.
42. Haynes RL, Folkerth RD, Keefe RJ, Sung I, Swzeda LI, Rosenberg PA, Volpe JJ, Kinney HC: Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia J Neuropathol Exp Neurol 2003;62:441-450.
43. Rezaie P, Male D: Colonisation of the developing human brain and spinal cord by microglia: a review. Microsc Res Tech 1999;45:359-382.
44. Smith ME, van der Maesen K, Somera FP: Macrophage and microglial responses to cytokines in vitro: phagocytic activity, proteolytic enzyme release, and free radical production J Neurosci Res 1998;54:68-78.
45. Dommergues MA, Plaisant F, Verney C, Gressens P: Early microglial activation following neonatal excitotoxic brain damage in mice: a potential target for neuroprotection. Neuroscience 2003;121:619-628.
46. Tahraoui SL, Marret S, Bodenant C, Leroux P, Dommergues MA, Evrard P, Gressens P: Central role of microglia in neonatal excitotoxic lesions of the murine periventricular white matter. Brain Pathol 2001;11:56-71.
47. Milatovic D, Zaja-Milatovic S, Montine KS, Shie FS, Montine TJ: Neuronal oxidative damage and dendritic degeneration following activation of CD14-dependent innate immune response in vivo. J Neuroinflammation 2004;1:20.
48. Monje ML, Toda H, Palmer TD: Inflammatory blockade restores adult hippocampal neurogenesis. Science 2003;302:1760-1765.
49. Crocker SJ, Pagenstecher A, Campbell IL: The TIMPs tango with MMPs and more in the central nervous system. J Neurosci Res 2004;75:1-11.
50. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes: Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 1995;273:413-418.
51. Garbrecht MR, Klein JM, Schmidt TJ, Snyder JM: Glucocorticoid metabolism in the human fetal lung: implications for lung development and the pulmonary surfactant system. Biol Neonate 2006;89:109-119.
52. Vayrynen O, Glumoff V, Hallman M: Inflammatory and anti-inflammatory responsiveness of surfactant proteins in fetal and neonatal rabbit lung. Pediatr Res 2004;55:55-60.
53. Massaro GD, Massaro D: Formation of alveoli in rats: postnatal effect of prenatal dexamethasone. Am J Physiol 1992;263:L37-L41.
54. Willet KE, Jobe AH, Ikegami M, Newnham J, Brennan S, Sly PD: Antenatal endotoxin and glucocorticoid effects on lung morphometry in preterm lambs. Pediatr Res 2000;48:782-788.
55. Tschanz SA, Haenni B, Burri PH: Glucocorticoid induced impairment of lung structure assessed by digital image analysis. Eur J Pediatr 2002;161:26-30.
56. Fayon M, Jouvencel P, Carles D, Choukroun ML, Marthan R: Differential effect of dexamethasone and hydrocortisone on alveolar growth in rat pups. Pediatr Pulmonol 2002;33:443-448.
57. Welberg LA, Seckl JR: Prenatal stress, glucocorticoids and the programming of the brain. J Neuroendocrinol 2001;13:113-128.
58. Matthews SG: Antenatal glucocorticoids and programming of the developing CNS. Pediatr Res 2000;47:291-300.
59. Slotkin TA, Zhang J, McCook EC, Seidler FJ: Glucocorticoid administration alters nuclear transcription factors in fetal rat brain: implications for the use of antenatal steroids. Brain Res Dev Brain Res 1998;111:11-24.
60. Kreider ML, Tate CA, Cousins MM, Oliver CA, Seidler FJ,, Slotkin TA: Lasting effects of developmental dexamethasone treatment on neural cell number and size, synaptic activity, and cell signaling: critical periods of vulnerability, dose-effect relationships, regional targets, and sex selectivity. Neuropsychopharmacology 2006;31:12-35.
61. Almeida OF, Conde GL, Crochemore C, Demeneix BA, Fischer D, Hassan AH, Meyer M, Holsboer F, Michaelidis TM: Subtle shifts in the ratio between pro- and antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate. FASEB J 2000;14:779-790.
62. Seckl JR, Cleasby M, Nyirenda MJ: Glucocorticoids, 11beta-hydroxysteroid dehydrogenase, and fetal programming. Kidney Int 2000;57:1412-1417.
63. Halliday HL: Postnatal steroids and chronic lung disease in the newborn. Paediatr Respir Rev 2004;5(suppl A):S245-S248.
64. Halliday HL, Ehrenkranz RA, Doyle LW: Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2003;CD001146.
65. Halliday HL, Ehrenkranz RA, Doyle LW: Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev 2003;CD001145.
66. Halliday HL, Ehrenkranz RA, Doyle LW: Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2003;CD001144.
67. Doyle LW, Halliday HL, Ehrenkranz RA, Davis PG, Sinclair JC: Impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk for chronic lung disease. Pediatrics 2005;115:655-661.
68. Shinwell ES, Karplus M, Reich D, Weintraub Z, Blazer S, Bader D, Yurman S, Dolfin T, Kogan A, Dollberg S, Arbel E, Goldberg M, Gur I, Naor N, Sirota L, Mogilner S, Zaritsky A, Barak M, Gottfried E: Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal Ed 2000;83:F177-F181.
69. Yeh TF, Lin YJ, Lin HC, Huang CC, Hsieh WS, Lin CH, Tsai CH: Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 2004;350:1304-1313.
70. Yeh TF, Lin YJ, Huang CC, Chen YJ, Lin CH, Lin HC, Hsieh WS, Lien YJ: Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics 1998;101:E7.
71. Baud O, Foix-L'Helias L, Kaminski M, Audibert F, Jarreau PH, Papiernik E, Huon C, Lepercq J, Dehan M, Lacaze-Masmonteil T: Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 1999;341:1190-1196.
72. Heide-Jalving M, Kamphuis PJ, van der Laan MJ, Bakker JM, Wiegant VM, Heijnen CJ, Veen S, van Bel F: Short- and long-term effects of neonatal glucocorticoid therapy: is hydrocortisone an alternative to dexamethasone? Acta Paediatr 2003;92:827-835.
73. Kasprian G, Balassy C, Brugger PC, Prayer D: MRI of normal and pathological fetal lung development. Eur J Radiol 2006;57:261-270.
74. Yamashita Y, Namimoto T, Abe Y, Takahashi M, Iwamasa J, Miyazaki K, Okamura H: MR imaging of the fetus by a HASTE sequence. AJR Am J Roentgenol 1997;168:513-519.
75. Keller TM, Rake A, Michel SC, Seifert B, Wisser J, Marincek B, Kubik-Huch RA: MR assessment of fetal lung development using lung volumes and signal intensities. Eur Radiol 2004;14:984-989.
76. Kuwashima S, Nishimura G, Iimura F, Kohno T, Watanabe H, Kohno A, Fujioka M: Low-intensity fetal lungs on MRI may suggest the diagnosis of pulmonary hypoplasia. Pediatr Radiol 2001;31:669-672.
77. Levine D, Barnewolt CE, Mehta TS, Trop I, Estroff J, Wong G: Fetal thoracic abnormalities: MR imaging. Radiology 2003;228:379-388.
78. Tanigaki S, Miyakoshi K, Tanaka M, Hattori Y, Matsumoto T, Ueno K, Uehara K, Nishimura O, Minegishi K, Ishimoto H, Shinmoto H, Ikeda K, Yoshimura Y: Pulmonary hypoplasia: prediction with use of ratio of MR imaging-measured fetal lung volume to US-estimated fetal body weight. Radiology 2004;232:767-772.
79. Willet KE, Jobe AH, Ikegami M, Kovar J, Sly PD: Lung morphometry after repetitive antenatal glucocorticoid treatment in preterm sheep. Am J Respir Crit Care Med 2001;163:1437-1443.
80. Leviton A, Paneth N: White matter damage in preterm newborns: an epidemiologic perspective. Early Hum Dev 1990;24:1-22.
81. Maalouf EF, Duggan PJ, Counsell SJ, Rutherford MA, Cowan F, Azzopardi D, Edwards AD: Comparison of findings on cranial ultrasound and magnetic resonance imaging in preterm infants. Pediatrics 2001;107:719-727.
82. Inder TE, Anderson NJ, Spencer C, Wells S, Volpe JJ: White matter injury in the premature infant: a comparison between serial cranial sonographic and MR findings at term AJNR Am J Neuroradiol 2003;24:805-809.
83. Childs A, Ramenghi L, Evans D, Ridgeway J, Saysell M, Martinez D, Arthur R, Tanner S, Levene M: MR Features of developing periventricular white matter in preterm infants: evidence of glial cell migration. AJNR Am J Neuroradiol 1998;19:971-976.
84. Huppi PS: Advances in postnatal neuroimaging: relevance to pathogenesis and treatment of brain injury. Clin Perinatol 2002;29:827-856.
85. Schouman-Claeys E, Henry-Feugeas MC, Roset F, Larroche JC, Hassine D, Sadik JC, Frija G, Gabilan JC: Periventricular leukomalacia: correlation between MR imaging and autopsy findings during the first 2 months of life. Radiology 1993;189:59-64.
86. Inder TE, Wells SJ, Mogridge NB, Spencer C, Volpe JJ: Defining the nature of the cerebral abnormalities in the premature infant: a qualitative magnetic resonance imaging study. J Pediatr 2003;143:171-179.
87. Ellison VJ, Mocatta TJ, Winterbourn CC, Darlow BA, Volpe JJ, Inder TE: The relationship of CSF and plasma cytokine levels to cerebral white matter injury in the premature newborn Pediatr Res 2005;57:282-286.
88. Inder T, Mocatta T, Darlow B, Spencer C, Volpe JJ, Winterbourn C: Elevated free radical products in the cerebrospinal fluid of VLBW infants with cerebral white matter injury. Pediatr Res 2002;52:213-218.
89. Neil J, Miller J, Mukherjee P, Huppi PS: Diffusion tensor imaging of normal and injured developing human brain: a technical review. NMR Biomed 2002;15:543-552.
90. Counsell SJ, Allsop JM, Harrison MC, Larkman DJ, Kennea NL, Kapellou O, Cowan FM, Hajnal JV, Edwards AD, Rutherford MA: Diffusion-weighted imaging of the brain in preterm infants with focal and diffuse white matter abnormality. Pediatrics 2003;112:1-7.
91. Miller SP, Vigneron DB, Henry RG, Bohland MA, Ceppi-Cozzio C, Hoffman C, Newton N, Partridge JC, Ferriero DM, Barkovich AJ: Serial quantitative diffusion tensor MRI of the premature brain: development in newborns with and without injury. J Magn Reson Imaging 2002;16:621-632.
92. Hüppi P, Murphy B, Maier S, Zientara G, Inder T, Barnes P, Kikinis R, Jolesz F, Volpe J: Microstructural brain development after perinatal cerebral white matter injury assessed by diffusion tensor magnetic resonance imaging. Pediatrics 2001;107:455-460.
93. Nagy Z, Westerberg H, Skare S, Andersson JL, Lilja A, Flodmark O, Fernell E, Holmberg K, Bohm B, Forssberg H, Lagercrantz H, Klingberg T: Preterm children have disturbances of white matter at 11 years of age as shown by diffusion tensor imaging. Pediatr Res 2003;54:672-679.
94. Seghier ML, Lazeyras F, Zimine S, Maier SE, Hanquinet S, Delavelle J, Volpe JJ, Huppi PS: Combination of event-related fMRI and diffusion tensor imaging in an infant with perinatal stroke. Neuroimage 2004;21:463-472.
95. Olesen PJ, Nagy Z, Westerberg H, Klingberg T: Combined analysis of DTI and fMRI data reveals a joint maturation of white and grey matter in a fronto-parietal network. Brain Res Cogn Brain Res 2003;18:48-57.
96. Hüppi P, Warfield S, Kikinis R, Barnes P, Zientara G, Jolesz F, Tsuji M, Volpe J: Quantitative magnetic resonance imaging of brain development in premature and mature newborns. Ann Neurol 1998;43:224-235.
97. Nosarti C, Al Asady MH, Frangou S, Stewart AL, Rifkin L, Murray RM: Adolescents who were born very preterm have decreased brain volumes. Brain 2002;125:1616-1623.
98. Inder T, Hüppi P, Warfield S, Kikinis R, Zientara G, Barnes P, Jolesz F, Volpe J: Periventricular white matter injury in the premature infant is associated with a reduction in cerebral cortical gray matter volume at term. Ann Neurol 1999;46:755-760.
99. Inder T, Neil J, Kroenke C, Dieni S, Yoder B, Rees S: Investigation of cerebral development and injury in the prematurely born primate by magnetic resonance imaging and histopathology. Dev Neurosci 2005;27:100-111.
100. Lodygensky GA, Rademaker K, Zimine S, Gex-Fabry M, Lieftink AF, Lazeyras F, Groenendaal F, de Vries LS, Huppi PS: Structural and functional brain development after hydrocortisone treatment for neonatal chronic lung disease. Pediatrics 2005;116:1-7.
101. Martinussen M, Fischl B, Larsson HB, Skranes J, Kulseng S, Vangberg TR, Vik T, Brubakk AM, Haraldseth O, Dale AM: Cerebral cortex thickness in 15-year-old adolescents with low birth weight measured by an automated MRI-based method. Brain 2005;128:2588-2596.
102. Modi N, Lewis H, Al Naqeeb N, Ajayi-Obe M, Dore CJ, Rutherford M: The effects of repeated antenatal glucocorticoid therapy on the developing brain. Pediatr Res 2001;50:581-585.
103. Murphy B, Inder T, Hüppi P, Zientara G, Warfield S, Kikinis R, Jolesz F, Volpe J: Impaired cerebral cortical gray matter growth following treatment with dexamethasone for neonatal chronic lung disease. Pediatrics 2001;107:217-221.